Title : Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Pub. Date : 2018 Nov

PMID : 30266998






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-kappaB nuclear translocation. Berberine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
2 Furthermore, pretreatment with berberine dose-dependently suppressed the nuclear-to cytosolic translocation of high-mobility group box1 (HMGB1) protein, the cytosolic-to nuclear translocation of nuclear factor kappa B (NF-kappaB) and decreased the expression of TLR4 in ischemic cortical tissue. Berberine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
3 Furthermore, pretreatment with berberine dose-dependently suppressed the nuclear-to cytosolic translocation of high-mobility group box1 (HMGB1) protein, the cytosolic-to nuclear translocation of nuclear factor kappa B (NF-kappaB) and decreased the expression of TLR4 in ischemic cortical tissue. Berberine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
4 Moreover, co-administration of glycyrrhizin and berberine exerted more potent suppression on the HMGB1/TLR4/NF-kappaB pathway than berberine or glycyrrhizin administered alone. Berberine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus
5 These results demonstrate that berberine protects the brain from ischemia-reperfusion injury and the mechanism may rely on its anti-inflammatory effects mediated by suppressing the activation of HMGB1/TLR4/NF-kappaB signaling. Berberine nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 Mus musculus